Filter
137
Filtered Results: 137
Text search:
Cochrane
Convenes
Featured
Recommendations
25
New Publications
35
Language
Document type
No document type
60
Guidelines
49
Studies & Reports
18
Manuals
5
Situation Updates
2
Fact sheets
2
Strategic & Response Plan
1
Countries / Regions
Global
4
Latin America and the Carribbean
2
Western and Central Europe
2
Sierra Leone
1
Syria
1
Qatar
1
Philippines
1
Guinea
1
Africa
1
Congo, Democratic Republic of
1
South–East Asia Region
1
North America
1
East and Southern Africa
1
Liberia
1
India
1
Authors & Publishers
Publication Years
Category
Maternal Health
23
Gynaecology & Obstetrics
17
Pediatrics
11
Paediatrics
9
Neonatal Care
6
TB
5
Child Health
4
Guidelines
4
HIV & STI
4
Under-5 nutrition
3
Bacteriology
3
Communicable Diseases
2
Community Health
2
Infection Control & Prevention (IPC)
2
NCD
2
Hemorrhagic Fever
2
Medical Devices & Equipment
2
Clinical Guidelines
2
Yellow Fever
2
WASH
2
Women & Child Health
2
Primary Health Care
2
Leishmaniasis
2
Reproductive Health
2
Hepatitis
1
Emergency Health Kits
1
Sanitation
1
Diabetes
1
Hand Hygiene
1
Taeniasis/ Cysticercosis
1
Cancer
1
General Guidelines
1
Monitoring & Evaluation
1
Breast Cancer
1
Water, Sanitation and Hygiene (WASH)
1
Vaccine-preventable Diseases
1
Cardiovascular Diseases
1
Studies & Reports
1
Palliative Care
1
Surgery & Anaesthesia
1
COPD/Asthma
1
Nutrition
1
Parasitology
1
Age & Elderly
1
Malaria
1
Pharmacy & Technologies
1
Toolboxes
Detection & Diagnosis
9
Drug resistant TB
5
Opportunistic Infections
4
Clinical Guidelines
4
Adults
3
Opoids
3
Midwives
3
Prevention & Strategies
3
Substance Use Disorders & Addiction
3
Gynaecology / Obstetrics
2
Treatment & Prevention
2
Children/Adolescents Mental Disorders
2
Children
2
Laboratory
2
Clinical Guidelines
2
Long COVID/ Post-COVID Syndrome
2
Drugs
1
ART Drug Resistance
1
Surveillance
1
Agriculture & Veterinary
1
Children with Disabilities
1
HIV testing & services
1
IPC
1
Ebola Prevention & Control
1
Clinical Aspects, Treatment & Prevention
1
Yellow Fever
1
Yellow Fever Prevention & Control
1
Prevention & Control
1
HIV surveillance
1
Children & Adolescents
1
Prevention Guidelines
1
Substance Use Disorders, Others
1
HIV testing & disclosure
1
Hepatitis
1
Public Health
1
mhGAP Guides
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Ebola
1
Drug resistance
1
Laboratory & Sampling
1
PPE Personel Protective Equipment
1
International
1
Cannabis
1
Treatment Guidelines
1
Prevention & Preparedness
1
Health Personnel
1
General
1
PPE Personel Protective Equipment
1
Clinical Guidelines
1
Global Impact: Socio-economic, health services, TB & HIV
1
Paediatrics
1
Medical & Community Masks
1
Infection Control & Prevention (IPC)
1
Blood Supply
1
TB/HIV
1
Standard Operating Procedure (SOP)
1
Hygiene
1
Handbooks & Manuals
1
Community Health Workers CHW
1
Palliative Care
1
Triage
1
Planetary Health
1
Biodiversity shift
1
Climate Change General
1
Advocacy
1
Mobility
1
Pediatrics
1
Cancer
1
Epilepsy
1
Prevention & Measures
1
Non-communicable Diseases NCD
1
Health Impact & Climate Change
1
More Clinical Guidelines on Palliative Care
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
General
1
Co-Morbidities (except TB)
1
Hearing Loss & Deafness
1
Autism
1
Alzheimer's Disease & Dementia
1
General Aspects
1
Assessment & Response
1
Malnutrition
1
Education of students & professionals
1
Training
1
Nutrition
1
Stewardship
1
HIV and coinfection
1
Testing Guidelines
1
Tobacco
1
Anxiety Disorders
1
WASH
1
Reports & Studies Children HIV
1
Paediatrics
1
Infection Control
1
Pregnant women
1
Mental Health GAP Action Programme
1
Universal Health Coverage & Primary Health Care
1
Preparedness & Prevention
1
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Recognition, Assessment and Treatment
National Clinical Guideline Number 159
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
Access to medical personal protective equipment (PPE) is essential for routine healthcare delivery, and a critical tool for containing outbreaks, as well as preventing and responding to pandemics. It is one of our most effective tools against COVID-19, and an undervalued tool more generally in infec...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a...
